August 11, 2022 Cost Estimate As ordered reported by the House Committee on the Judiciary on September 30, 2021 View Document172.44 KB Summary H.R. 2884 would limit the number of patents that could be included in infringement claims for biological products. Legislative Information Available From Congress.gov Related Publications Estimated Budgetary Effects of S. 1435, the Affordable Prescriptions for Patients Act of 2021June 6, 2022
H.R. 2884 would limit the number of patents that could be included in infringement claims for biological products.
